Investor attention is fixed on Hypoport SE this Monday, March 30, as the financial services provider releases its complete annual report for 2025. The publication arrives at a precarious moment for the company’s equity, which is trading at a multi-year low, leaving the market in a state of tense anticipation for new details.
A Market Out of Sync with Operational Results
Operationally, the preliminary figures for 2025 present a relatively positive story. Revenue reached approximately 603 million euros, while the gross profit advanced by roughly 10% to 266 million euros. These signs of recovery within Hypoport’s core business of real estate and mortgage platforms were initially communicated by the company in February.
Despite these operational improvements, the market’s valuation tells a different story. Hypoport’s current market capitalization sits at only about 504 million euros. This significant discount highlights deep-seated investor skepticism regarding the durability of the reported recovery. From a technical analysis perspective, the share price is nearly 46% below its 200-day moving average, and a Relative Strength Index (RSI) reading of 17 indicates a severely oversold condition.
Should investors sell immediately? Or is it worth buying Hypoport?
Key Details in the Spotlight
The full report will place two critical elements under the microscope. First, the complete cash flow statement will be scrutinized for insights into the company’s financial health beyond profitability. Second, and arguably more important, will be the concrete guidance and outlook provided for the 2026 financial year.
Previously, Hypoport’s management has projected a continuation of its margin expansion, citing a medium-term goal of doubling its EBIT margin. The market will judge whether Monday’s document provides a credible and substantive foundation for this ambitious target. The stock closed Friday’s session at 71.00 euros, marking a fresh 52-week low. While technical rebounds from such extreme oversold levels are historically common, any sustained recovery is contingent on the annual report containing no negative surprises.
Ad
Hypoport Stock: Buy or Sell?! New Hypoport Analysis from March 28 delivers the answer:
The latest Hypoport figures speak for themselves: Urgent action needed for Hypoport investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 28.
Hypoport: Buy or sell? Read more here...
